About SR-18292
Thiamet-G is actually a extremely distinct OGA inhibitor that was synthesized based upon rationale structure [23]. Initial studies indicated this compound decrease tau phosphorylation at some phosphorylation sites that may be abnormally phosphorylated in AD [23], suggesting that OGA inhibition might provide a potential therapeutic approach for slow